0.7765
price down icon0.46%   -0.0036
after-market アフターアワーズ: .80 0.0235 +3.03%
loading

Atossa Therapeutics Inc (ATOS) 最新ニュース

pulisher
Aug 16, 2025

Atossa Therapeutics reports progress in breast cancer treatments - MSN

Aug 16, 2025
pulisher
Aug 16, 2025

Technical analysis overview for Atossa Therapeutics Inc. stockJuly 2025 Closing Moves & Target Return Focused Stock Picks - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

How Atossa Therapeutics Inc. stock performs during market volatilityQuarterly Market Review & Weekly Momentum Picks - newsyoung.net

Aug 16, 2025
pulisher
Aug 16, 2025

Building trade automation scripts for Atossa Therapeutics Inc.July 2025 Update & Consistent Return Strategy Ideas - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Can momentum traders help lift Atossa Therapeutics Inc.2025 Year in Review & Long-Term Capital Growth Ideas - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Chart overlay techniques for tracking Atossa Therapeutics Inc.Watch List & Accurate Technical Buy Alerts - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

What the charts say about Atossa Therapeutics Inc. todayWeekly Trend Report & Smart Money Movement Alerts - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

What recovery options are there for Atossa Therapeutics Inc.July 2025 EndofMonth & Pattern Based Trade Signal System - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

HC Wainwright Expects Reduced Earnings for Atossa Genetics - Defense World

Aug 16, 2025
pulisher
Aug 15, 2025

Does Atossa Therapeutics Inc. show high probability of reboundQuarterly Profit Summary & Long Hold Capital Preservation Tips - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Multi asset correlation models including Atossa Therapeutics Inc.Market Growth Summary & Fast Gain Swing Trade Alerts - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Trendlines Converge — Decision Point for Atossa Therapeutics Inc.July 2025 Selloffs & Weekly High Return Stock Opportunities - beatles.ru

Aug 15, 2025
pulisher
Aug 15, 2025

Published on: 2025-08-15 04:52:23 - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Will Atossa Therapeutics Inc. benefit from macro trendsEarnings Trend Report & Long Hold Capital Preservation Plans - Newser

Aug 15, 2025
pulisher
Aug 14, 2025

Why Atossa Therapeutics Inc. stock attracts strong analyst attentionWeekly Risk Report & Risk Controlled Daily Plans - Newser

Aug 14, 2025
pulisher
Aug 14, 2025

Technical Heatmap Flags Atossa Therapeutics Inc. for WatchMarket Volume Summary & Fast Gain Swing Alerts - newsyoung.net

Aug 14, 2025
pulisher
Aug 14, 2025

What makes Atossa Therapeutics Inc. stock price move sharplyBuy Signal & Low Drawdown Trading Strategies - Newser

Aug 14, 2025
pulisher
Aug 14, 2025

Should you wait for a breakout in Atossa Therapeutics Inc.IPO Watch & Low Drawdown Investment Strategies - Newser

Aug 14, 2025
pulisher
Aug 13, 2025

Ranking Atossa Therapeutics Inc. among high performing stocks via toolsTrade Analysis Summary & AI Optimized Trade Strategies - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Atossa Therapeutics Advances Breast Cancer Treatments - TipRanks

Aug 13, 2025
pulisher
Aug 13, 2025

What does recent volatility data suggest for Atossa Therapeutics Inc. [July 2025 News Drivers]Weekly Breakout Opportunity Watchlist - Newser

Aug 13, 2025
pulisher
Aug 12, 2025

Atossa Therapeutics Inc. stock momentum explainedDaily Breakout List with Smart Filters - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

H.C. Wainwright Maintains Atossa Therapeutics(ATOS.US) With Buy Rating, Maintains Target Price $7 - 富途牛牛

Aug 12, 2025
pulisher
Aug 12, 2025

Applying sector rotation models to Atossa Therapeutics Inc. [July 2025 Rallies]Risk Controlled Stock Pick Alerts - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

Atossa Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener

Aug 12, 2025
pulisher
Aug 12, 2025

Short Term Charts Align With Long Term Uptrend in Atossa Therapeutics Inc.Growth Based Stock Signal Screener Updated - 선데이타임즈

Aug 12, 2025
pulisher
Aug 12, 2025

Atossa Therapeutics' Q2 2025 Earnings: Navigating Financial Losses and the Promise of (Z)-endoxifen in Metastatic Breast Cancer - AInvest

Aug 12, 2025
pulisher
Aug 12, 2025

Atossa Therapeutics Q2 2025 Financial Results and Corporate Update - TradingView

Aug 12, 2025
pulisher
Aug 12, 2025

FDA Fast-Tracks Atossa's Breast Cancer Drug as Clinical Trial Shows 77% Tumor Reduction - Stock Titan

Aug 12, 2025
pulisher
Aug 12, 2025

Risk vs reward if holding onto Atossa Therapeutics Inc.Free Pattern Alert With ROI Driven Strategy - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

Atossa Therapeutics Announces Second Quarter 2025 Financial Results and Provides a Corporate Update - Ariva

Aug 12, 2025
pulisher
Aug 10, 2025

Atossa Therapeutics and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Pensacola News Journal

Aug 10, 2025
pulisher
Aug 10, 2025

How moving averages guide Atossa Therapeutics Inc. tradingEquity Market Return Forecast Model Update - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

New Product Launches: Will They Boost Atossa Therapeutics Inc. Stock in 2025Free Sector Rotation Based Trading Opportunities - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

Is Atossa Therapeutics Inc. building a consolidation baseTrade Signal Summary & Consistent Profit Trade Alerts - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

What does recent volatility data suggest for Atossa Therapeutics Inc.Secure Trading Strategy Based on Technical Analysis - Newser

Aug 10, 2025
pulisher
Aug 09, 2025

Atossa Therapeutics Inc. Uptrend in Early Stages Indicators Say YesReversal Alert Based on RSI Indicator Confirmed - beatles.ru

Aug 09, 2025
pulisher
Aug 09, 2025

Published on: 2025-08-09 01:47:05 - Newser

Aug 09, 2025
pulisher
Aug 09, 2025

Atossa Genetics (ATOS) Expected to Announce Earnings on Monday - Defense World

Aug 09, 2025
$36.35
price down icon 0.41%
$86.92
price up icon 0.88%
$26.69
price up icon 0.91%
$127.80
price up icon 0.04%
$113.52
price up icon 0.73%
biotechnology ONC
$321.36
price up icon 3.77%
大文字化:     |  ボリューム (24 時間):